Biology subjects

Doberstein, K.

Publications and source records attributed to Doberstein, K..

4 recordsLinked to original sources

bioRxiv2025

Interplay between BET Proteins and the Pre-Replication Complex Unveils Therapeutic Vulnerabilities in Cancer

Replication stress is a critical event in cancer development and understanding the underlying molecular mechanisms can help to identify new treatment strategies. Here, we investigate the molecular interplay between the pre-replication complex (pre-RC) and the bromodomain and extraterminal domain (BET) proteins in orchestrating replication stress response. Our findings reveal a mutual dependency between BET proteins and the pre-RC within cancer cells. Notably, reduction in origin licensing or replication initiation makes cells more susceptible to the BET-inhibitor AZD5153. Furthermore, we observe synergistic effects when combining the CDC7 inhibitor XL413 with AZD5153, effects which were partly dependent on TP53 mutation status. This combination treatment results in unresolved DNA damage and R-loop formation, leading to increased genomic instability. These insights pave the way for novel strategies for targeted cancer therapies and provide a foundation for further investigation into the interplay between CDC7 and BET proteins in replication stress response. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=194 SRC="FIGDIR/small/645172v2_ufig1.gif" ALT="Figure 1"> View larger version (85K): org.highwire.dtl.DTLVardef@f5b170org.highwire.dtl.DTLVardef@545fbeorg.highwire.dtl.DTLVardef@159b631org.highwire.dtl.DTLVardef@c851cf_HPS_FORMAT_FIGEXP M_FIG C_FIG The graphic illustrates how the CDC7 inhibitor XL413 and the BET inhibitor AZD5153 work together in TP53-deficient cancer cells. First, XL413 prevents activation of the origin of replication complex, leading to DNA damage. Second, the DNA repair machinery is unable to resolve this damage, resulting in the accumulation of unresolved R-loops and genomic instability. Ultimately, this cascade culminates in cell death.

cancer biology↗

bioRxiv2023

Inhibition of Replication Origins and ATR Synergistically Activates the Innate Immune System in Cancer Cells

Sufficient numbers of activated replication origins are essential for successful DNA replication. While normal cells load replication origins in abundance to the genome, cancer cells often load fewer origins of replication due to genomic alterations such as CCNE1 amplifications. Here we exploit this feature to sensitize cancer cells to ATR inhibition. We show by using siRNA and small molecules that the inhibition of origin activation as well as the reduction of replication origins itself sensitizes ovarian cancer cell lines against ATR inhibition by inducing genomic instability. We further show that in ovarian cancer cells this combinatorial approach leads to an increased genomic instability which manifests in an increase of micronuclei that consequently activate the innate immune system through the cGAS-STING pathway. Notably, no activation of the innate immune system was observed in immortalized fallopian tube cells. However, overexpression of Cyclin E1 in this model leads to a marked increase in genomic instability and innate immune activation. Here we provide preclinical evidence to increase the therapeutic efficacy of ATR inhibitors. Additionally, this approach could help to activate innate immunity and increase T-cell immune infiltration in tumors, providing a rationale for a combination with immune checkpoint inhibitors.

cancer biology↗

bioRxiv2018

Replication stress induced by CCNE1 overexpression creates a dependency on XRCC2 at the replication fork

Across multiple cancer types, genome instability has been linked to aberrant over-expression of CCNE1 due to premature cell cycle entry and replication stress. Using a gain-of-function screen, we found that XRCC2 cooperates with CCNE1 in the neoplastic transformation of TP53 mutant cells. A pan-cancer analysis of TCGA data revealed a striking correlation between CCNE1 and XRCC2 expression and knockdown of XRCC2 in Cyclin E1 overexpressing cell lines is synthetic lethal. Immunopurification of XRCC2 showed that it interacts with the Minichromosome Maintenance Complex Component 7 (MCM7) protein. This interaction appears to be critical for protecting replication forks as knockdown of XRCC2 leads to a strong increase in MCM7 ubiquitination with concomitant decrease in MCM7 protein levels, and reduced replication fork speed. Importantly, Overexpression of MCM7 rescues the effect of XRCC2 knockdown. Our data describe a new dependency of Cyclin E1 overexpressing tumors on factors that stabilize the replication fork.

molecular biology↗

bioRxiv2018

Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis

Most high-grade serous ovarian carcinomas (HGSC) arise from Serous Tubal Intraepithelial Carcinoma (STIC) lesions in the distal end of the fallopian tube (FT). FT secretory cells become malignant by accumulating genomic aberrations over 6-7 years before seeding the ovarian surface, with rapid tumor dissemination to other abdominal structures thereafter. It remains unclear how nascent malignant cells leave the FT to colonize the ovary. This report provides evidence that the L1 cell adhesion molecule (L1CAM) contributes to the ability of transformed FT secretory cells (FTSEC) to detach from the tube, survive under anchorage-independent conditions, and seed the ovarian surface. L1CAM was highly expressed on the apical surface of STIC lesions and contributed to ovarian colonization by upregulating integrin and fibronectin in malignant cells and activating the AKT and ERK pathways. These changes increased cell survival under ultra-low attachment conditions that mimic transit from the FT to the ovary. To study metastasis to the ovary, we developed a tumor-ovary co-culture model. We showed that L1CAM expression was important for FT cells to invade the ovary as a cohesive group. Our results indicate that in the early stages of HGSC development, transformed FTSECs disseminate from the FT to the ovary in L1CAM-dependent manner.\n\nThe authors have declared that no conflict of interest exists\n\nList of abbreviations

cancer biology↗